Evaxion Biotech AS (EVAX)
3.72
-0.11
(-2.87%)
USD |
NASDAQ |
May 17, 16:00
3.72
0.00 (0.00%)
After-Hours: 20:00
Evaxion Biotech Accounts Payable (Quarterly): 2.689M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.689M |
| September 30, 2023 | |
| June 30, 2023 | 1.685M |
| March 31, 2023 | |
| December 31, 2022 | 2.085M |
| September 30, 2022 | |
| June 30, 2022 | 2.439M |
| March 31, 2022 | 2.486M |
| Date | Value |
|---|---|
| December 31, 2021 | 2.848M |
| September 30, 2021 | 0.538M |
| June 30, 2021 | 1.552M |
| March 31, 2021 | 3.408M |
| December 31, 2020 | 3.673M |
| September 30, 2020 | 1.502M |
| December 31, 2019 | 0.646M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.538M
Minimum
Sep 2021
3.673M
Maximum
Dec 2020
2.129M
Average
2.262M
Median
Accounts Payable (Quarterly) Benchmarks
| DBV Technologies SA | 18.08M |
| Ascendis Pharma A/S | 102.08M |
| Cellectis SA | 19.07M |
| Adaptimmune Therapeutics PLC | 8.128M |
| Akari Therapeutics PLC | 1.671M |